Skip to main content
Top
Published in: Diabetologia 3/2012

01-03-2012 | Article

TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition

Authors: C. E. Hills, E. Siamantouras, S. W. Smith, P. Cockwell, K.-K. Liu, P. E. Squires

Published in: Diabetologia | Issue 3/2012

Login to get access

Abstract

Aims/hypothesis

A key pathology in diabetic nephropathy is tubulointerstitial fibrosis. The condition is characterised by increased deposition of the extracellular matrix, fibrotic scar formation and declining renal function, with the prosclerotic cytokine TGF-β1 mediating many of these catastrophic changes. Here we investigated whether TGF-β1-induced epithelial-to-mesenchymal transition (EMT) plays a role in alterations in cell adhesion, cell coupling and cell communication in the human renal proximal tubule.

Methods

Whole-cell and cell compartment abundance of E-cadherin, N-cadherin, snail, vimentin, β-catenin and connexin-43 was determined in human kidney cell line (HK)2 and human proximal tubule cells with or without TGF-β1, using western blotting and immunocytochemistry, followed by quantification by densitometry. The contribution of connexin-43 in proximal tubule cell communication was quantified using small interfering RNA knockdown, while dye-transfer was used to assess gap junctional intercellular communication (GJIC). Functional tethering was assessed by single-cell force spectroscopy with or without TGF-β1, or by immunoneutralisation of cadherin ligation.

Results

High glucose (25 mmol/l) increased the secretion of TGF-β1 from HK2 cells. Analysis confirmed early TGF-β1-induced morphological and phenotypical changes of EMT, with altered levels of adhesion and adherens junction proteins. These changes correlated with impaired cell adhesion and decreased tethering between coupled cells. Impaired E-cadherin-mediated adhesion reduced connexin-43 production and GJIC, these effects being mimicked by neutralisation of E-cadherin ligation. Upregulation of N-cadherin failed to restore adhesion or connexin-43-mediated GJIC.

Conclusions/interpretation

We provide compelling evidence that TGF-β1-induced EMT instigates a loss of E-cadherin, cell adhesion and ultimately of connexin-mediated cell communication in the proximal tubule under diabetic conditions; these changes occur ahead of overt signs of renal damage.
Appendix
Available only for authorised users
Literature
1.
go back to reference Eddy AA (1996) Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 12:2495–2508 Eddy AA (1996) Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 12:2495–2508
2.
go back to reference Remuzzi G, Ruggenenti P, Benigni A (1997) Understanding the nature of renal disease progression. Kidney Int 51:2–15PubMedCrossRef Remuzzi G, Ruggenenti P, Benigni A (1997) Understanding the nature of renal disease progression. Kidney Int 51:2–15PubMedCrossRef
3.
go back to reference Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341–350PubMed Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341–350PubMed
4.
go back to reference Okada H, Danoff TM, Kalluri R, Neilson EG (1997) Early role of Fsp1 in epithelial–mesenchymal transformation. Am J Physiol 273:F563–F574PubMed Okada H, Danoff TM, Kalluri R, Neilson EG (1997) Early role of Fsp1 in epithelial–mesenchymal transformation. Am J Physiol 273:F563–F574PubMed
5.
go back to reference Hills CE, Squires PE (2010) TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol 31:68–74PubMedCrossRef Hills CE, Squires PE (2010) TGF-beta1-induced epithelial-to-mesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol 31:68–74PubMedCrossRef
6.
go back to reference Kanwar YS, Wada J, Sun L et al (2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 233:4–11CrossRef Kanwar YS, Wada J, Sun L et al (2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med 233:4–11CrossRef
7.
go back to reference Sharma K, Ziyadeh FN (1995) Hyperglycaemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139–1146PubMedCrossRef Sharma K, Ziyadeh FN (1995) Hyperglycaemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139–1146PubMedCrossRef
8.
go back to reference Oldfield MD, Bach LA, Forbes JM et al (2001) Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108:1853–1863PubMed Oldfield MD, Bach LA, Forbes JM et al (2001) Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108:1853–1863PubMed
9.
go back to reference Qi W, Chen X, Zhang Y et al (2007) High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism. Nephrol Dial Transplant 11:3147–3153CrossRef Qi W, Chen X, Zhang Y et al (2007) High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism. Nephrol Dial Transplant 11:3147–3153CrossRef
10.
go back to reference Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural functional relationships in DN. J Clin Invest 74:1143–1155PubMedCrossRef Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural functional relationships in DN. J Clin Invest 74:1143–1155PubMedCrossRef
11.
go back to reference Steffes MW, Osterby R, Chavers B, Mauer SM (1989) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077–1081PubMedCrossRef Steffes MW, Osterby R, Chavers B, Mauer SM (1989) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077–1081PubMedCrossRef
12.
go back to reference Hills CE, Al-Rasheed N, Al-Rasheed N, Willars GB, Brunskill NJ (2009) C-peptide reverses TGF-beta-1 induced changes in renal proximal tubular cells: implications for treatment of DN. Am J Physiol 296:F614–F621 Hills CE, Al-Rasheed N, Al-Rasheed N, Willars GB, Brunskill NJ (2009) C-peptide reverses TGF-beta-1 induced changes in renal proximal tubular cells: implications for treatment of DN. Am J Physiol 296:F614–F621
13.
go back to reference Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803–36810PubMedCrossRef Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803–36810PubMedCrossRef
14.
go back to reference Masszi A, Fan L, Rosivall L et al (2004) Integrity of cell–cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 165:1955–1967PubMedCrossRef Masszi A, Fan L, Rosivall L et al (2004) Integrity of cell–cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 165:1955–1967PubMedCrossRef
15.
go back to reference Zheng G, Lyons JG, Tan TK et al (2009) Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial–mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 175:580–591PubMedCrossRef Zheng G, Lyons JG, Tan TK et al (2009) Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial–mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. Am J Pathol 175:580–591PubMedCrossRef
16.
go back to reference Moreno AP, Berthoud VM, Pérez-Palacios G, Pérez-Armendariz EM (2005) Biophysical evidence that connexin-36 forms functional gap junction channels between pancreatic mouse beta-cells. Am J Physiol Endocrinol Metab 288:E948–E956PubMedCrossRef Moreno AP, Berthoud VM, Pérez-Palacios G, Pérez-Armendariz EM (2005) Biophysical evidence that connexin-36 forms functional gap junction channels between pancreatic mouse beta-cells. Am J Physiol Endocrinol Metab 288:E948–E956PubMedCrossRef
17.
go back to reference Boggon TJ, Murray J, Chappuis-Flament S, Wong E, Gumbiner BM, Shapiro L (2002) C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 17:1308–1313CrossRef Boggon TJ, Murray J, Chappuis-Flament S, Wong E, Gumbiner BM, Shapiro L (2002) C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 17:1308–1313CrossRef
18.
go back to reference Fujimoto K, Nagafuchi A, Tsukita S, Kuraoka A, Ohokuma A, Shibata Y (1997) Dynamics of connexins, E-cadherin and alpha-catenin on cell membranes during gap junction formation. J Cell Sci 110:311–322PubMed Fujimoto K, Nagafuchi A, Tsukita S, Kuraoka A, Ohokuma A, Shibata Y (1997) Dynamics of connexins, E-cadherin and alpha-catenin on cell membranes during gap junction formation. J Cell Sci 110:311–322PubMed
19.
go back to reference Caton D, Calabrese A, Mas C, Serre-Beinier V, Wonkam A, Meda P (2002) Beta-cell crosstalk: a further dimension in the stimulus-secretion coupling of glucose-induced insulin release. Diabetes Metab 28:3S45–S53PubMed Caton D, Calabrese A, Mas C, Serre-Beinier V, Wonkam A, Meda P (2002) Beta-cell crosstalk: a further dimension in the stimulus-secretion coupling of glucose-induced insulin release. Diabetes Metab 28:3S45–S53PubMed
20.
go back to reference Kanno Y, Sasaki Y, Shiba Y, Yoshida-Noro C, Takeichi M (1984) Monoclonal antibody ECCD-1 inhibits intercellular communication in teratocarcinoma PCC3 cells. Exp Cell Res 152:270–274PubMedCrossRef Kanno Y, Sasaki Y, Shiba Y, Yoshida-Noro C, Takeichi M (1984) Monoclonal antibody ECCD-1 inhibits intercellular communication in teratocarcinoma PCC3 cells. Exp Cell Res 152:270–274PubMedCrossRef
21.
go back to reference Musil LS, Cunningham BA, Edelman GM, Goodenough DA (1990) Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J Cell Biol 111:2077–2088PubMedCrossRef Musil LS, Cunningham BA, Edelman GM, Goodenough DA (1990) Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J Cell Biol 111:2077–2088PubMedCrossRef
22.
go back to reference Mege RM, Matsuzaki F, Gallin WJ, Goldberg JI, Cunningham BA, Edelman GM (1988) Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules. Proc Natl Acad Sci U S A 85:7274–7278PubMedCrossRef Mege RM, Matsuzaki F, Gallin WJ, Goldberg JI, Cunningham BA, Edelman GM (1988) Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules. Proc Natl Acad Sci U S A 85:7274–7278PubMedCrossRef
23.
go back to reference Bobbie MW, Roy S, Trudeau K, Munger SJ, Simon AM, Roy S (2001) Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Opthalmol Vis Sci 51:3758–3763CrossRef Bobbie MW, Roy S, Trudeau K, Munger SJ, Simon AM, Roy S (2001) Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. Invest Opthalmol Vis Sci 51:3758–3763CrossRef
24.
go back to reference Li AF, Roy S (2009) High glucose induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest Opthalmol Vis Sci 50:1400–1407CrossRef Li AF, Roy S (2009) High glucose induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest Opthalmol Vis Sci 50:1400–1407CrossRef
25.
go back to reference Zhang J, Hill CE (2005) Differential connexin expression in preglomerular and postglomerular vasculature: accentuation during diabetes. Kidney Int 68:1171–1185PubMedCrossRef Zhang J, Hill CE (2005) Differential connexin expression in preglomerular and postglomerular vasculature: accentuation during diabetes. Kidney Int 68:1171–1185PubMedCrossRef
26.
go back to reference Zhang JH, Kawashima S, Yokoyama M, Huang P, Hill CE (2006) Increased eNOS accounts for changes in connexin expression in renal arterioles during diabetes. Anat Rec A Discov Mol Cell Evol Biol 288:1000–1008PubMed Zhang JH, Kawashima S, Yokoyama M, Huang P, Hill CE (2006) Increased eNOS accounts for changes in connexin expression in renal arterioles during diabetes. Anat Rec A Discov Mol Cell Evol Biol 288:1000–1008PubMed
27.
go back to reference Li AF, Sato T, Haimovici R, Okamoto T, Roy S (2003) High glucose alters connexin 43 expression and gap junction intercellular communication activity in retinal pericytes. Invest Ophthalmol Vis Sci 44:5376–5382PubMedCrossRef Li AF, Sato T, Haimovici R, Okamoto T, Roy S (2003) High glucose alters connexin 43 expression and gap junction intercellular communication activity in retinal pericytes. Invest Ophthalmol Vis Sci 44:5376–5382PubMedCrossRef
28.
go back to reference Sato T, Haimovici R, Kao R, Li AF, Roy S (2002) Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes 51:1565–1571PubMedCrossRef Sato T, Haimovici R, Kao R, Li AF, Roy S (2002) Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes 51:1565–1571PubMedCrossRef
29.
go back to reference Fernandes R, Girão H, Pereira P (2004) High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J Biol Chem 279:27219–27224PubMedCrossRef Fernandes R, Girão H, Pereira P (2004) High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J Biol Chem 279:27219–27224PubMedCrossRef
30.
go back to reference Gomes P, Malfait M, Himpens B, Vereecke J (2003) Intercellular Ca(2+)-transient propagation in normal and high glucose solutions in rat retinal epithelial (RPE-J) cells during mechanical stimulation. Cell Calcium 34:185–192PubMedCrossRef Gomes P, Malfait M, Himpens B, Vereecke J (2003) Intercellular Ca(2+)-transient propagation in normal and high glucose solutions in rat retinal epithelial (RPE-J) cells during mechanical stimulation. Cell Calcium 34:185–192PubMedCrossRef
31.
go back to reference Hanner F, Sorensen CM, Holstein-Rathlou NH, Peti-Peterdi J (2010) Connexins and the kidney. Am J Physiol Regul Integr Comp Physiol 298:R1143–R1155PubMedCrossRef Hanner F, Sorensen CM, Holstein-Rathlou NH, Peti-Peterdi J (2010) Connexins and the kidney. Am J Physiol Regul Integr Comp Physiol 298:R1143–R1155PubMedCrossRef
32.
go back to reference Hills CE, Bland R, Bennett J, Ronco PM, Squires PE (2006) High glucose up-regulates ENaC and SGK1 expression in HCD-cells. Cell Physiol Biochem 18:337–346PubMedCrossRef Hills CE, Bland R, Bennett J, Ronco PM, Squires PE (2006) High glucose up-regulates ENaC and SGK1 expression in HCD-cells. Cell Physiol Biochem 18:337–346PubMedCrossRef
33.
go back to reference Hills CE, Bland R, Wheelans DC, Bennett J, Ronco PM, Squires PE (2006) Glucose-evoked alterations in connexin43-mediated cell-to-cell communication in human collecting duct: a possible role in diabetic nephropathy. Am J Physiol Renal Physiol 291:F1045–F1051PubMedCrossRef Hills CE, Bland R, Wheelans DC, Bennett J, Ronco PM, Squires PE (2006) Glucose-evoked alterations in connexin43-mediated cell-to-cell communication in human collecting duct: a possible role in diabetic nephropathy. Am J Physiol Renal Physiol 291:F1045–F1051PubMedCrossRef
34.
go back to reference Tian YC, Fraser D, Attisano L, Phillips AO (2003) TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 285:F130–F142PubMed Tian YC, Fraser D, Attisano L, Phillips AO (2003) TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am J Physiol Renal Physiol 285:F130–F142PubMed
35.
go back to reference Hills CE, Willars GB, Brunskill NJ (2010) Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways. Mol Endocrinol 24:822–831PubMedCrossRef Hills CE, Willars GB, Brunskill NJ (2010) Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways. Mol Endocrinol 24:822–831PubMedCrossRef
36.
go back to reference Tian YC, Phillips AO (2002) Interaction between the transforming growth factor-β type II receptor/Smad pathway and β-catenin during transforming growth factor-β1-mediated adherens junction disassembly. Am J Pathol 160:1619–1628PubMedCrossRef Tian YC, Phillips AO (2002) Interaction between the transforming growth factor-β type II receptor/Smad pathway and β-catenin during transforming growth factor-β1-mediated adherens junction disassembly. Am J Pathol 160:1619–1628PubMedCrossRef
37.
go back to reference Maeda M, Johnson K, Wheelock MJ (2005) Cadherin switching: essential for behavioural but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 118:873–887PubMedCrossRef Maeda M, Johnson K, Wheelock MJ (2005) Cadherin switching: essential for behavioural but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 118:873–887PubMedCrossRef
38.
go back to reference Strutz F, Zeisberg M (2006) Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17:2992–2998PubMedCrossRef Strutz F, Zeisberg M (2006) Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol 17:2992–2998PubMedCrossRef
39.
go back to reference Humphreys BD, Lin SL, Kobayashi A et al (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85–97PubMedCrossRef Humphreys BD, Lin SL, Kobayashi A et al (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176:85–97PubMedCrossRef
40.
go back to reference Keeley EC, Mehrad B, Strieter RM (2010) Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 42:535–542PubMedCrossRef Keeley EC, Mehrad B, Strieter RM (2010) Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 42:535–542PubMedCrossRef
41.
go back to reference Zeisberg M, Duffield JS (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247–1253PubMedCrossRef Zeisberg M, Duffield JS (2010) Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21:1247–1253PubMedCrossRef
42.
go back to reference Hills CE, Squires PE (2011) The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev 22:131–139PubMed Hills CE, Squires PE (2011) The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev 22:131–139PubMed
43.
go back to reference Dennler S, Itoh S, Vivien D, Dijke P, Huet S, Gauthier J (1998) Direct binding of smad3 and smad4 to critical TGF-β inducible elements in the promoter of the human plasminogen activator inhibitor-type 1 gene. EMBO 17:3091–3100CrossRef Dennler S, Itoh S, Vivien D, Dijke P, Huet S, Gauthier J (1998) Direct binding of smad3 and smad4 to critical TGF-β inducible elements in the promoter of the human plasminogen activator inhibitor-type 1 gene. EMBO 17:3091–3100CrossRef
44.
go back to reference Yang F, Huang XR, Chung AC, Hou CC, Lai KN, Lan HY (2010) Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. J Pathol 221:390–401PubMed Yang F, Huang XR, Chung AC, Hou CC, Lai KN, Lan HY (2010) Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. J Pathol 221:390–401PubMed
45.
go back to reference Yeh YC, Wei WC, Wang YK, Lin SC, Sung JM, Tang MJ (2010) Transforming growth factor-β1 induces Smad3-dependent β1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol 177:1743–1754PubMedCrossRef Yeh YC, Wei WC, Wang YK, Lin SC, Sung JM, Tang MJ (2010) Transforming growth factor-β1 induces Smad3-dependent β1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol 177:1743–1754PubMedCrossRef
46.
go back to reference Brown KA, Pietenpol JA, Moses HL (2007) A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 101:9–33PubMedCrossRef Brown KA, Pietenpol JA, Moses HL (2007) A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 101:9–33PubMedCrossRef
47.
go back to reference Tan R, Zhang J, Tan X, Zhang X, Yang J, Liu Y (2006) Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. J Am Soc Nephrol 17:2781–2791PubMedCrossRef Tan R, Zhang J, Tan X, Zhang X, Yang J, Liu Y (2006) Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. J Am Soc Nephrol 17:2781–2791PubMedCrossRef
48.
go back to reference Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY (2002) Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13:1464–1472PubMedCrossRef Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY (2002) Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13:1464–1472PubMedCrossRef
49.
go back to reference Takenaka T, Inoue T, Okada H et al (2011) Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes. Diabetologia 54:2192–2201PubMedCrossRef Takenaka T, Inoue T, Okada H et al (2011) Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes. Diabetologia 54:2192–2201PubMedCrossRef
50.
go back to reference Liu L, Hu X, Cai GY et al (2011) High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 over-expression via PTEN/Akt/mTOR signaling. Nephrol Dial Transplant. doi:10.1093/ndt/gfr265 Liu L, Hu X, Cai GY et al (2011) High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 over-expression via PTEN/Akt/mTOR signaling. Nephrol Dial Transplant. doi:10.​1093/​ndt/​gfr265
Metadata
Title
TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition
Authors
C. E. Hills
E. Siamantouras
S. W. Smith
P. Cockwell
K.-K. Liu
P. E. Squires
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-011-2409-9

Other articles of this Issue 3/2012

Diabetologia 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.